Nobel Biocare Acquires BioCad -- a Leading Developer of Computer-aided Design Software for Prosthetics for EUR 26 Million

ZURICH, Switzerland, Nov. 11, 2008 (GLOBE NEWSWIRE) -- Nobel Biocare announced today that it has signed an agreement to buy 100% of BioCad Medical Inc., a leading developer of computer-aided software for prosthetics, for a total amount of approximately EUR 26 million (approximately CHF 39 million). At the same time, Nobel Biocare also announced the signing of an exclusive partnership with Optimet, Optical Metrology Ltd, to offer a new generation of optical scanners with impression scanning capabilities. Along with the acquisition and the partnership, Nobel Biocare will introduce a broad range of new prosthetic materials and products. Hence, Nobel Biocare will be in a position to provide dental professionals a leading optical scanner and CAD/CAM software, the most comprehensive material and product offer, and unique manufacturing capabilities for prosthetics. This complete range will be presented at all major industry events including CDS, AO and IDS in early 2009 and launched thereafter.